Table 2.
Case No. | Gender | Age of Onset(Year) | First Symptoms | Stage | Transfer Site | Treatment | Recur | Prognosis |
---|---|---|---|---|---|---|---|---|
1 | Female | 7.5 | Rash, precocious puberty | II | None | Surgery - chemotherapy | No | CR |
2 | Female | 1.6 | Rash, precocious puberty | IV | Lung | Biopsy - Chemotherapy - Surgery - Chemotherapy | No | SD |
3 | Female | 6.5 | Rash, precocious puberty | IV | Lung | Surgery-chemotherapy-relapse-surgery, radiation therapy-chemotherapy | Yes | CR |
4 | Male | 6 | Abdominal pain | IV | Lung | Biopsy - Chemotherapy - Surgery - Chemotherapy | No | CR |
5 | Female | 4.9 | Headache, precocious puberty | IV | Lung, liver | Chemotherapy - Surgery - Chemotherapy | No | Death |
6 | Female | 3.5 | Precocious puberty | IV | Lung, liver, lymph node | Chemotherapy - Surgery - Chemotherapy | No | Death |
7 | Female | 12 | Abdominal pain | II | None | Surgery - chemotherapy | No | CR |
8 | Male | 6 | Headache | IV | Lung, liver | Surgery - chemotherapy | No | SD |
Notes: All lesions had completely disappeared for more than four weeks. The primary tumor reduced by ≥ 64%, the metastatic tumor reduced by ≥ 30%, there were no new lesions. The primary tumor increased by ≥40% compared to its size at the initial diagnosis, the metastasis tumor increased by ≥20%, new lesions appeared. Tumor volume was between PD and PR.
Abbreviations: ACC, adrenocortical carcinoma; CR, complete remission; PR, partial remission; PD, disease progression; SD, stable disease.